SEC Form D · filed May 14, 2015
Nora Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Donald K. Hayden, Jr · Palo Alto, CADirectorChen K. Yu · Palo Alto, CADirectorJeffrey K. Tong · Palo Alto, CAExec · DirectorMartin K. Vogelbaum · Palo Alto, CADirectorAnupam K. Dalal · Palo Alto, CADirectorDennis K. Fenton · Palo Alto, CADirectorDavid K. Schnell · Palo Alto, CADirectorJoseph L. Turner, Jr · Palo Alto, CADirectorShoaib Makani · San Francisco, CADirectorPaul P. Horan · Kennett Square, PADirectorSusan M. Oswald · Westport, CTDirectorTerry Opdendyk · Palo Alto, CADirectorRobert Hull · Palo Alto, CADirectorChris Agerton · San Francisco, CAExec · DirectorByron Deeter · Palo Alto, CADirectorJef J. Boeke · New York, NYDirectorRobert Antoniades · Palo Alto, CAExec · DirectorFloyd N. Tyler · Memphis, TNDirectorJim Kelliher · Palo Alto, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗